logo
Select company
Select metric
-715.36%EBIT Margin
VS
Market
6
Sector
21
Industry
38
History
93
$ 3.04Close
$ 0.42 - $ 4.74 52-Week Range
Ticker Information

Ticker

ABVC

Company Name

ABVC BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABVC BIOPHARMA INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABVC - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -2.8M-715.36%$ 391.24K
3/31/2025$ -1.56M-306.53%$ 508.38K
12/31/2024$ -4.19M-821.74%$ 509.59K
9/30/2024$ -5.91M-1159.46%$ 509.79K
6/30/2024$ -8.04M-5897.54%$ 136.4K
3/31/2024$ -9.25M-36460.87%$ 25.36K
12/31/2023$ -7.77M-5095%$ 152.43K
9/30/2023$ -9.7M-1312.2%$ 739.26K
6/30/2023$ -11.17M-1459.53%$ 765.64K
3/31/2023$ -11.03M-1028.95%$ 1.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABVC BIOPHARMA INC's latest trailing twelve months (TTM) EBIT % stands at -3312.73%.
  • Over the past 5 years, ABVC BIOPHARMA INC's average EBIT % has been -5529.78%.
  • The median EBIT % for ABVC BIOPHARMA INC during this period was -1580.92%
  • ABVC BIOPHARMA INC reached its highest EBIT % over the past 5 years at -306.53%.
  • The lowest EBIT % recorded by ABVC BIOPHARMA INC in the same timeframe -36460.87%

ABVC BIOPHARMA INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
RPTX : REPARE THERAPEUTICS INC -43504.4%COEP : COEPTIS THERAPEUTICS HOLDINGS INC -3832.35%COYA : COYA THERAPEUTICS INC -4973.22%INO : INOVIO PHARMACEUTICALS INC -48131.35%AVTX : AVALO THERAPEUTICS INC -10946.03%MNOV : MEDICINOVA INC -8771.68%CLNN : CLENE INC -9398.6%APLT : APPLIED THERAPEUTICS INC -55523.77%ENTX : ENTERA BIO LTD -6378.31%PULM : PULMATRIX INC -2149.05%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for ABVC BIOPHARMA INC is calculated as follows: EBIT [ $ -11.79M ] / Revenues [ $ 355.8K ]
(=) EBIT % [ -3312.73% ]

ABVC - EBIT Margin, Last 5 years

-36460.87%

Minimum

Mar 31, 2024

-306.53%

Maximum

Mar 31, 2025

-5529.78%

Average

-1580.92%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%